United States

Hunan Er-Kang Pharmaceutical Co Ltd (300267.SZ)

300267.SZ on Shenzhen Stock Exchange

21 Mar 2018
Change (% chg)

¥-0.06 (-0.85%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Fangwen Shuai

48 2015 Chairman of the Board

Zhenya Gao

43 2013 Chief Financial Officer

Aijun Liu

41 2015 General Manager

Lang Luo

34 2012 Secretary of the Board, Deputy General Manager

Xiangfeng Wang

46 Deputy General Manager, Director